CCDC77 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.729800E-01
Normal-vs-Stage2
5.897800E-01
Normal-vs-Stage3
1.547600E-01
Normal-vs-Stage4
2.845800E-01
Stage1-vs-Stage2
9.121400E-01
Stage1-vs-Stage3
3.316200E-01
Stage1-vs-Stage4
9.929400E-01
Stage2-vs-Stage3
4.305400E-01
Stage2-vs-Stage4
7.385200E-01
Stage3-vs-Stage4
2.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.853200E-01
Normal-vs-AfricanAmerican
1.984010E-01
Normal-vs-Asian
5.472300E-02
Caucasian-vs-AfricanAmerican
5.331400E-01
Caucasian-vs-Asian
4.931500E-02
AfricanAmerican-vs-Asian
2.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.579600E-01
Normal-vs-Female
2.605200E-01
Male-vs-Female
4.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.689000E-01
Normal-vs-Age(41-60Yrs)
3.388200E-01
Normal-vs-Age(61-80Yrs)
5.843400E-01
Normal-vs-Age(81-100Yrs)
6.835800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.040600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.976600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.790600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.631400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.233400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.117600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.780800E-01
Normal-vs-Daily Drinker
1.070170E-01
Normal-vs-Weekly Drinker
3.345400E-01
Normal-vs-Occasional Drinker
3.410000E-01
Normal-vs-Social Drinker
5.888600E-01
Non Drinker-vs-Daily Drinker
3.976400E-01
Non Drinker-vs-Weekly Drinker
6.027200E-01
Non Drinker-vs-Occasional Drinker
6.356000E-01
Non Drinker-vs-Social Drinker
8.816400E-01
Daily Drinker-vs-Weekly Drinker
6.820200E-01
Daily Drinker-vs-Occasional Drinker
5.803600E-01
Daily Drinker-vs-Social Drinker
4.782200E-01
Weekly Drinker-vs-Occasional Drinker
9.287800E-01
Weekly Drinker-vs-Social Drinker
7.204200E-01
Occasional Drinker-vs-Social Drinker
7.528400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.437200E-01
Normal-vs-Grade 2
7.990600E-01
Normal-vs-Grade 3
7.006400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.313000E-01
Grade 1-vs-Grade 3
7.976800E-01
Grade 1-vs-Grade 4
7.437200E-01
Grade 2-vs-Grade 3
9.063600E-01
Grade 2-vs-Grade 4
7.990600E-01
Grade 3-vs-Grade 4
7.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.783800E-01
Normal-vs-NonDiabetic
3.758200E-01
Diabetic-vs-NonDiabetic
6.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.265800E-01
Normal-vs-NoPancreatitis
4.826800E-01
Pancreatitis-vs-NoPancreatitis
5.524000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.534800E-01
Normal-vs-N1
4.871400E-01
N0-vs-N1
8.265400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.025000E-01
Normal-vs-TP53-NonMutant
8.476000E-01
TP53-Mutant-vs-TP53-NonMutant
7.487200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
